An essential component of allogeneic and autologous hematopoietic cell transplantation
(HCT) is the conditioning regimen administered before the hematopoietic cell infusion. Early …

Treatment of B-cell non-Hodgkin's lymphoma has become more successful, largely owing to
the availability of therapeutic monoclonal antibodies, which may avoid the toxic effects of …

The International Commission on Radiation Units and Measurements (ICRU), since its
inception in 1925, has had as its principal objective the development of internationally …

The incidence of lymphoma has gradually increased over previous decades, and it ranks
among the ten most prevalent cancers worldwide. With the development of targeted …

Histologic transformation of follicular lymphoma to an aggressive non-Hodgkin lymphoma is
a critical biologic event with profound implications on the natural history of this otherwise …

Major advances have been made in the field of immunology in the past two decades. A
better understanding of the molecular and cellular mechanisms controlling the immune …

Mantle cell lymphoma is included in the World Health Organization classification as distinct
lymphoma subtype characterized by the t (11; 14)(q13; q32) translocation, which results in …

Targeting of radionuclides with antibodies, or radioimmunotherapy, has been an active field
of research spanning nearly 50 years, evolving with advancing technologies in molecular …

The main objective of the MCL3 study was to improve outcome for patients not in complete
remission (CR) before transplant by adding 90Y-ibritumomab-tiuxetan (Zevalin) to the high …

BACKGROUND: High‐dose chemotherapy combined with autologous stem‐cell
transplantation (ASCT) is the standard therapy for refractory/relapsed aggressive lymphoma …